Search Results 1801-1810 of 14763 for anti-TNF drugs

  1. Teriflunomide (Oral Route) Proper Use - Mayo Clinic

    Teriflunomide may stay in your blood for up to 2 years after your treatment. Your doctor may want you to use activated charcoal or cholestyramine (Questran®) to ...

  2. Difenoxin And Atropine (Oral Route) Description and Brand Names - Mayo Clinic

    Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Motofen. Descriptions. Difenoxin and atropine ...

  3. Teclistamab-Cqyv (Subcutaneous Route) Proper Use - Mayo Clinic

    Medicines used to treat cancer are very strong and can have many side effects. Before receiving this medicine, make sure you understand all the risks and ...

  4. Overview - RNA Nanotherapeutics: Tushar C. Patel

    Novel discoveries in liver cancer. Our lab is investigating the mechanisms behind cancer and the response to cancer treatment to drive improvements in early ...

  5. Antifibrotics may extend lives for patients with IPF - Mayo Clinic News Network

    Mayo Clinic researchers recently learned that patients who are taking antifibrotic drugs for idiopathic pulmonary fibrosis (IPF) have a better chance of ...

  6. Tegaserod (Oral Route) Description and Brand Names - Mayo Clinic

    Your doctor will then contact FDA's Division for Drug Information about the emergency IND process at druginfo@fda.hhs.gov. This medicine is available only with ...

  7. Interferon Beta-1a (Intramuscular Route, Subcutaneous Route) Proper Use - Mayo Clinic

    Do not use any other needle for the prefilled autoinjector pen. Each package of medicine contains a Medication Guide and a sheet called Instructions for Use.

  8. Overview - Molecular Neurotherapeutics - Mayo Clinic Research

    D., focuses on the identification and therapeutic intervention of target molecules and cell types for the treatment or prevention of neurodegenerative disorders ...

  9. Brentuximab (Intravenous Route) Precautions - Mayo Clinic

    Men should use an effective form of birth control to avoid pregnancy in sexual partners during treatment and for at least 4 months after the last dose. If you ...

  10. A Study of Lutetium Lu 177 Dotatate (Lutathera®) in Patients with Inoperable, Progressive Meningioma after External Beam Radiation Therapy - Mayo Clinic

    The purpose of this study is to estimate the efficacy of LUTATHERA treatment in patients with recurrent grade 1 meningioma as measured by 6-month PFS rate, and ...